A pilot study to determine whether increasing oxygen flow rate or oxygen percentage through a fixed performance mask relieves breathlessness in patients with cystic fibrosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN60112193

Enrollment

Registered

2006-09-29

Start date

2005-07-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine: Cystic fibrosis Nutritional, Metabolic, Endocrine Cystic fibrosis

Interventions

Cohort of stable CF Patients. Patients will perform a maximal bicycle ergometric exercise test on room air (under supervision of a specialist CF physiotherapist and doctor) to determine work rate & as

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cystic fibrosis patients aged over 16 2. Clinically stable 3. Able to give informed consent

Exclusion criteria

Exclusion criteria: Patients having respiratory exacerbation

Design outcomes

Primary

Measure	Time frame
Increasing oxygen flow rate is beneficial to breathless patients	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026